Corosolic acid exerts its antidiabetic effects by regulating insulin receptor substrate-1 (IRS-1), protein kinase B (Akt), and liver kinase B1 (LkB1), thereby mitigating adenosine monophosphate-activated protein kinase (AMPK) activation to alleviate insulin resistance [26]. The gene discussed is STK11; the disease is Insulin resistance.